Prevention of Pioglitazone Induced Weight Gain by Co Administration of Piperine

Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 7, Issue 4

Abstract

Aim: Diabetes is the most common and one of the leading causes of mortality among non communicable diseases. Pilogitazone is the potent PPARr agonist used for the treatment of diabetes. The drug is associated with a substantial weight gain. The aim of this present study is to try to reduce the drug associated weight gain by co-administration with Piperine. Methods: Alloxan induced diabetic model was taken as experimental method. After induction of diabetes (except in Group I), animals were classified into five groups, Group I and II were not given with any treatment and they served as normal control and diabetic control groups respectively. Group III, IV and V were given with Pioglitazone (2 mg/Kg PO), Piperine (2 mg/Kg PO) and co-administration of both at 2 mg/Kg PO respectively for 4 weeks. After completion of 4 weeks, the blood samples of the animals were estimated for the glucose levels to analyze the diabetic action and the lipid profile along with observation of body weight, food intake and water intake to analyze weight gain. Results: There was a good control over the blood sugar levels in all the treated groups (≈ 120 mg/dL) except in diabetic control group (330.0±9.661 mg/dL). Along with a control over diabetes, Piperine and Pioglitazone treated animals resulted in reduced lipid profiles and not much increase in weight gain (1.243±0.137%) when compared to monotherapy of Pioglitazone (8.818±0.846%). Conclusion: Co administration of Piperine in diabetic treatment with Pioglitazone may be a beneficial attempt to reduce weight gain.

Authors and Affiliations

Bindu Madhavi Boddupalli, Ramalingam Ramani, Ravinder Nath Anisetti, Vijaya Lakshmi Chandragiri

Keywords

Related Articles

Potential for a Beneficial Effect of Theophylline on Extended Acute Inflammation: Review

Inflammation is often prolonged after sepsis, trauma and other acute pro-inflammatory events, particularly above the age of 80 years. Exposure to inflammation of inappropriate amplitude or duration is associated with a h...

Simultaneous Determination of Ternary Mixture of Aspirin, Caffeine and Orphenadrine Citrate by Simple RP-TLC Spectrodensitometric Method

Aims: A simple TLC Spectrodensitometric method was developed for analysis of Orphenadrine Citrate (OR), Caffeine (CAF) and Aspirin (ASP) either in pure form or in their pharmaceutical preparations. Study Design: Validati...

Assessment of Haematological and Biochemical Effects of Kolaviron in Male Wistar Rats

This study determined the effects of kolaviron on the hematological and biochemical parameters of rats. The aim was to ascertain if its consumption has deleterious effects on these parameters. Forty adult male Wistar rat...

Spectroscopic Characterization and Antibiotic Study of Novel Compound Extracted from Curcuma longa (Turmeric)

Aims: To isolate and investigate the antibacterial potency of novel compound obtained from methanolic extract of Curcuma longa rhizome. Place and Duration of Study: Bio-inorganic and Materials Chemistry Research laborato...

Factors Influencing Job Motivation of Hospital Pharmacists

Aims: The study aimed to explore for factors influencing job motivation of hospital pharmacists. Study Design: A cross sectional descriptive survey. Place and Duration of Study: The study was conducted at Obafemi Awolo...

Download PDF file
  • EP ID EP344512
  • DOI 10.9734/BJPR/2015/18416
  • Views 70
  • Downloads 0

How To Cite

Bindu Madhavi Boddupalli, Ramalingam Ramani, Ravinder Nath Anisetti, Vijaya Lakshmi Chandragiri (2015). Prevention of Pioglitazone Induced Weight Gain by Co Administration of Piperine. Journal of Pharmaceutical Research International, 7(4), 276-281. https://europub.co.uk/articles/-A-344512